Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{familytree/start |summary= Algorithm for diagnosis of CUP}} | {{familytree/start |summary= Algorithm for diagnosis of CUP}} | ||
{{familytree | {{familytree | | | | | | | | | | | A01 | | | | | | |A01=Tumor of unknown primary origin}} | ||
{{familytree | {{familytree | | | | | | | | | | | |!| | | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | | | |boxstyle=text-align: left; | B01 | | | | | | |B01= • Full medical history and physical exam<br> • Basic blood and bichemical analysis<br> • CT scan of chest, abdomen, and pelvis}} | ||
{{familytree | {{familytree | | | | | | | | | | | |!| | | | | | | | | }} | ||
{{familytree | {{familytree | | | | | | | | | | | C01 | | | | | | |C01=Histopathologic examination}} | ||
{{familytree | {{familytree | | | | |,|-|-|-|-|-|-|+|-|-|-|-|-|.| | }} | ||
{{familytree | {{familytree | | | |D01| | | | | D02| | | | D03 |D01='''Squamous cell carcinoma'''|D02='''Neuroendocrine carcinoma'''|D03='''Adenocarcinoma and poorly differntiated carcinoma'''}} | ||
{{familytree | {{familytree | | | | |!| | | | | | |!| | | | | |!| | }} | ||
{{familytree | | | | | | {{familytree | | | | |!| | | | | |boxstyle=text-align: left;|E01| | | | |!| |E01=• Octreoscan<br> • Plasma chromogranin A}} | ||
{{familytree | {{familytree | | | |F01| | | | | | | | | | | F02 | |F01=Additional tests specific to location of metastasis|F02=Gender specific tests}} | ||
{{familytree | |, | {{familytree | | | | |!| | | | | | | | | | | | |!| | }} | ||
{{familytree | | {{familytree | |,|-|-|+|-|-|-|.| | | | | | |,|-|^|-|.| | }} | ||
{{familytree | G01| |G02| | G03 | | | | G04 | | G05 | |G01=Cervical adenopathy|G02=Inguinal adenopathy|G03=Bone metastasis|G04=Male|G05=Female}} | |||
{{familytree/end}} | {{familytree/end}} |
Revision as of 20:27, 10 October 2018
Tumor of unknown primary origin | |||||||||||||||||||||||||||||||||||||||||||
• Full medical history and physical exam • Basic blood and bichemical analysis • CT scan of chest, abdomen, and pelvis | |||||||||||||||||||||||||||||||||||||||||||
Histopathologic examination | |||||||||||||||||||||||||||||||||||||||||||
Squamous cell carcinoma | Neuroendocrine carcinoma | Adenocarcinoma and poorly differntiated carcinoma | |||||||||||||||||||||||||||||||||||||||||
• Octreoscan • Plasma chromogranin A | |||||||||||||||||||||||||||||||||||||||||||
Additional tests specific to location of metastasis | Gender specific tests | ||||||||||||||||||||||||||||||||||||||||||
Cervical adenopathy | Inguinal adenopathy | Bone metastasis | Male | Female | |||||||||||||||||||||||||||||||||||||||